Merkel cell carcinoma of the head and neck: Pathogenesis, current and emerging treatment options

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 2157-2167

  Saini, Alok T ^a   Miles, Brett A ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

Merkel cells; Neuroendocrine cancer; Polyomavirus; Skin cancer

Indexed keywords

CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CHEMOSURGERY; COMPUTER ASSISTED TOMOGRAPHY; DRUG TARGETING; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LYMPH NODE; MERKEL CELL TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT OUTCOME;

EID: 84939795585     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S72202     Document Type: Review

References (147)

1. Merkel F. Tastzellen and Tastkörperchen bei den Hausthieren und beim Menschen. Arch Mikrosk Anat. 1875;11:636.
2. Woo SH, Lumpkin EA, Patapoutian A. Merkel cells and neurons keep in touch. Trends Cell Biol. 2015;25(2):74-81.
3. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1): 107-110.
4. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer. 1978;42(5):2311-2321.
5. Hitchcock CL, Bland KI, Laney RG 3rd, Franzini D, Harris B, Copeland EM 3rd. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg. 1988;207(2):201-207.
6. Koljonen V. Merkel cell carcinoma. World J Surg Oncol. 2006;4:7.
7. Smith VA, Camp ER, Lentsch EJ. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data. Laryngoscope. 2012;122(6):1283-1290.
8. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375-381.
9. Kempf W, Mertz KD, Hofbauer GF, Tinguely M. Skin cancer in organ transplant recipients. Pathobiology. 2013;80(6):302-309.
10. Koljonen V, Kukko H, Tukiainen E, et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant. 2009;24(10):3231-3235.
11. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet. 2002;359(9305):497-498.
12. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832-841.
13. Marcoval J, Ferreres JR, Penín RM, Pérez D, Viñals JM. Merkel cell carcinoma: differences between sun­exposed and non­sun­exposed variants - a clinical analysis of 36 cases. Dermatology. 2014;229(3):205-209.
14. Agelli M, Clegg LX, Becker JC, Rollison DE. The etiology and epidemiology of Merkel cell carcinoma. Curr Probl Cancer. 2010;34(1):14-37.
15. Huber GF. Modern management of Merkel cell carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2014;22(2):109-115.
16. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37(1):20-27.
17. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89(1):1-4.
18. Becker JC. Merkel cell carcinoma. Ann Oncol. 2010;21(Suppl 7): vii81-vii85.
19. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992;140(2):427-447.
20. Kaae J, Hansen AV, Biggar RJ, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst. 2010;102(11): 793-801.
21. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866): 1096-1100.
22. Arora R, Chang Y, Moore PS. MCV and Merkel cell carcinoma: a molecular success story. Curr Opin Virol. 2012;2(4):489-498.
23. MartelJantin C, Pedergnana V, Nicol JT, et al. Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings. J Clin Virol. 2013;58(1):288-291.
24. Tolstov YL, Knauer A, Chen JG, et al. Asymptomatic primary Merkel cell polyomavirus infection among adults. Emerg Infect Dis. 2011;17(8): 1371-1380.
25. Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. Merkel cell polyomavirus and two previously unknown polyomavi­ ruses are chronically shed from human skin. Cell Host Microbe. 2010; 7(6):509-515.
26. Coursaget P, Samimi M, Nicol JT, Gardair C, Touzé A. Human Merkel cell polyomavirus: virological background and clinical implications. APMIS. 2013;121(8):755-769.
27. Signorini L, Belingheri M, Ambrogi F, et al. High frequency of Merkel cell polyomavirus DNA in the urine of kidney transplant recipients and healthy controls. J Clin Virol. 2014;61(4):565-570.
28. Zhang C, Liu F, He Z, et al. Seroprevalence of Merkel cell polyomavirus in the general rural population of Anyang, China. PLoS One. 2014; 9(9):e106430.
29. Dalianis T, Hirsch HH. Human polyomaviruses in disease and cancer. Virology. 2013;437(2):63-72.
30. Mangana J, Dziunycz P, Kerl K, Dummer R, Cozzio A. Prevalence of Merkel cell polyomavirus among Swiss Merkel cell carcinoma patients. Dermatology. 2010;221(2):184-188.
31. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E­BP1 translation regulator. J Clin Invest. 2011;121(9):3623-3634.
32. Arora R, Shuda M, Guastafierro A, et al. Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med. 2012;4(133):133ra56.
33. Houben R, Schrama D, Becker JC. Molecular pathogenesis of Merkel cell carcinoma. Exp Dermatol. 2009;18(3):193-198.
34. Paulson KG, Carter JJ, Johnson LG, et al. Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients. Cancer Res. 2010;70(21):8388-8397.
35. Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst. 2009;101(13):938-945.
36. Veija T, Sahi H, Koljonen V, Bohling T, Knuutila S, Mosakhani N. miRNA­34a underexpressed in Merkel cell polyomavirus­negative Merkel cell carcinoma. Virchows Arch. 2015;466(3):289-295.
37. Kuwamoto S. Recent advances in the biology of Merkel cell carcinoma. Hum Pathol. 2011;42(8):1063-1077.
38. Houben R, Grimm J, Willmes C, Weinkam R, Becker JC, Schrama D. Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit­ and­run oncogenesis. J Invest Dermatol. 2012;132(1):254-256.
39. Fischer N, Brandner J, Fuchs F, Moll I, Grundhoff A. Detection of Merkel cell polyomavirus (MCPyV) in Merkel cell carcinoma cell lines: cell morphology and growth phenotype do not reflect presence of the virus. Int J Cancer. 2010;126(9):2133-2142.
40. Shuda M, Feng H, Kwun HJ, et al. T antigen mutations are a human tumor­specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A. 2008;105(42):16272-16277.
41. Houben R, Angermeyer S, Haferkamp S, et al. Characterization of functional domains in the Merkel cell polyoma virus Large T antigen. Int J Cancer. 2015;136(5):E290-E300.
42. Shahzad N, Shuda M, Gheit T, et al. The T antigen locus of Merkel cell polyomavirus downregulates human Toll­like receptor 9 expression. J Virol. 2013;87(23):13009-13019.
43. Griffiths DA, AbdulSada H, Knight LM, et al. Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling. J Virol. 2013;87(24):13853-13867.
44. Knight LM, Stakaityte G1, Wood JJ, et al. Merkel cell polyomavirus small T antigen mediates microtubule destabilization to promote cell motility and migration. J Virol. 2015;89(1):35-47.
45. Kassem A, Technau K, Kurz AK, et al. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer. 2009;125(2):356-361.
46. Scola N, Wieland U, Silling S, Altmeyer P, Stücker M, Kreuter A. Preva­ lence of human polyomaviruses in common and rare types of non­Merkel cell carcinoma skin cancer. Br J Dermatol. 2012;167(6):1315-1320.
47. Wetzels CT, Hoefnagel JG, Bakkers JM, Dijkman HB, Blokx WA, Melchers WJ. Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung. PLoS One. 2009;4(3):e4958.
48. SastreGarau X, Peter M, Avril MF, et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol. 2009;218(1):48-56.
49. Chun SM, Yun SJ, Lee SC, Won YH, Lee JB. Merkel cell polyomavirus is frequently detected in Korean patients with Merkel cell carcinoma. Ann Dermatol. 2013;25(2):203-207.
50. Hattori T, Takeuchi Y, Takenouchi T, et al. The prevalence of Merkel cell polyomavirus in Japanese patients with Merkel cell carcinoma. J Dermatol Sci. 2013;70(2):99-107.
51. Matsushita M, Iwasaki T, Kuwamoto S, et al. Merkel cell polyomavirus (MCPyV) strains in Japanese Merkel cell carcinomas (MCC) are distinct from Caucasian type MCPyVs: genetic variability and phylogeny of MCPyV genomes obtained from Japanese MCPyV­infected MCCs. Virus Genes. 2014;48(2):233-242.
52. Martel-Jantin C, Filippone C, Tortevoye P, et al. Molecular epidemiology of Merkel cell polyomavirus: evidence for geographically related variant genotypes. J Clin Microbiol. 2014;52(5):1687-1690.
53. Ramahi E, Choi J, Fuller CD, Eng TY. Merkel cell carcinoma. Am J Clin Oncol. 2013;36(3):299-309.
54. Becker J, Mauch C, Kortmann RD, et al. Short German guidelines: Merkel cell carcinoma. J Dtsch Dermatol Ges. 2008;6(Suppl 1):S15-S16.
55. Knoepp SM, Hookim K, Placido J, Fields KL, Roh MH. The application of immunocytochemistry to cytologic direct smears of metastatic Merkel cell carcinoma. Diagn Cytopathol. 2013;41(8):729-733.
56. Dancey AL, Rayatt SS, Soon C, Ilchshyn A, Brown I, Srivastava S. Merkel cell carcinoma: a report of 34 cases and literature review. J Plast Reconstr Aesthet Surg. 2006;59(12):1294-1299.
57. Bobos M, Hytiroglou P, Kostopoulos I, Karkavelas G, Papadimitriou CS. Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol. 2006;28(2): 99-104.
58. Kontochristopoulos GJ, Stavropoulos PG, Krasagakis K, Goerdt S, Zouboulis CC. Differentiation between Merkel cell carcinoma and malignant melanoma: an immunohistochemical study. Dermatology. 2000; 201(2):123-126.
59. Agaimy A, Erlenbach-Wünsch K, Konukiewitz B, et al. ISL1 expression is not restricted to pancreatic well­differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Mod Pathol. 2013; 26(7):995-1003.
60. Kao CS, Warren S, Idrees MT. Merkel cell carcinoma exhibiting cytoplasmic OCT4 staining: a potential new diagnostic immunohis­ tochemical marker. Am J Dermatopathol. 2014;36(3):274-276.
61. Lombardi D, Accorona R, Ungari M, Melocchi L, Bell D, Nicolai P. Primary Merkel cell carcinoma of the submandibular gland: when CK20 status complicates the diagnosis. Head Neck Pathol. 2015;9(2): 309-314.
62. Snow SN, Larson PO, Hardy S, et al. Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa. Dermatol Surg. 2001;27(2):165-170.
63. Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol. 1997; 21(2):226-234.
64. Fisher CA, Harms PW, McHugh JB, et al. Small cell carcinoma in the parotid harboring Merkel cell polyomavirus. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118(6):703-712.
65. Chen MM, Roman SA, Sosa JA, Judson BL. The role of adjuvant therapy in the management of head and neck Merkel cell carcinoma: an analysis of 4815 patients. JAMA Otolaryngol Head Neck Surg. 2015;141(2): 137-141.
66. Henderson SA, Tetzlaff MT, Pattanaprichakul P, et al. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. J Cutan Pathol. 2014;41(11):846-852.
67. Tarantola TI, Vallow LA, Halyard MY, et al. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol. 2013; 68(3):425-432.
68. Samimi M, Touzé A, Laude H, et al. Vitamin D deficiency is associated with greater tumor size and poorer outcome in Merkel cell carcinoma patients. J Eur Acad Dermatol Venereol. 2014;28(3):298-308.
69. Behr DS, Peitsch WK, Hametner C, et al. Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD­L1 expression in Merkel cell carcinomas. Int J Clin Exp Pathol. 2014;7(11):7610-7621.
70. Sihto H, Joensuu H. Tumor­infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus­associated cancer. Oncoimmunology. 2012;1(8):1420-1421.
71. Kouzmina M, Leikola J, Böhling T, Koljonen V. Positive sentinel lymph node biopsy predicts local metastases during the course of disease in Merkel cell carcinoma. J Plast Surg Hand Surg. 2013;47(2): 139-143.
72. Santamaria-Barria JA, Boland GM, Yeap BY, Nardi V, DiasSantagata D, Cusack JC Jr. Merkel cell carcinoma: 30­year experience from a single institution. Ann Surg Oncol. 2013;20(4):1365-1373.
73. Iyer JG, Storer BE2, Paulson KG, et al. Relationships among primary tumor size, number of involved nodes, and survival for 8,044 cases of Merkel cell carcinoma. J Am Acad Dermatol. 2014;70(4):637-643.
74. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5,823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63(5):751-761.
75. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
76. Gupta SG, Wang LC, Peñas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana­Farber experience and meta­analysis of the literature. Arch Dermatol. 2006;142(6):685-690.
77. Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma. Head Neck. 2011;33(9):1260-1264.
78. Peloschek P, Novotny C, Mueller-Mang C, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol. 2010;73(2): 317-323.
79. Colgan MB, Tarantola TI, Weaver AL, et al. The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma. J Am Acad Dermatol. 2012;67(6):1250-1256.
80. Enzenhofer E, Ubl P, Czerny C, Erovic BM. Imaging in patients with Merkel cell carcinoma. J Skin Cancer. 2013;2013:973123.
81. Zager JS, Brodsky S, Berman CG. Imaging of Merkel cell carcinoma. Curr Probl Cancer. 2010;34(1):65-76.
82. Anderson SE, Beer KT, Banic A, et al. MRI of Merkel cell carcinoma: histologic correlation and review of the literature. AJR Am J Roentgenol. 2005;185(6):1441-1448.
83. Gollub MJ, Gruen DR, Dershaw DD. Merkel cell carcinoma: CT findings in 12 patients. AJR Am J Roentgenol. 1996;167(3):617-620.
84. Treglia G, Kakhki VR, Giovanella L, Sadeghi R. Diagnostic performance of fluorine­18­fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta­analysis. Am J Clin Dermatol. 2013;14(6):437-447.
85. Concannon R, Larcos GS, Veness M. The impact of (18)F­FDG PET­CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol. 2010;62(1):76-84.
86. Hawryluk EB, O’Regan KN, Sheehy N, et al. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana­Farber/Brigham and Women’s Cancer Center. J Am Acad Dermatol. 2013;68(4):592-599.
87. Moshiri AS, Nghiem P. Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw. 2014;12(9): 1255-1262.
88. Schneider S, Thurnher D, Erovic BM. Merkel cell carcinoma: interdisciplinary management of a rare disease. J Skin Cancer. 2013;2013: 189342.
89. Morand G, Vital D, Pézier T, et al. Merkel cell carcinoma of the head and neck: a single institutional experience. J Skin Cancer. 2013;2013: 325086.
90. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001; 127(2):149-154.
91. O’Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty­six patients. Dermatol Surg. 1997;23(10):929-933.
92. Gollard R, Weber R, Kosty MP, Greenway HT, Massullo V, Humberson C. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer. 2000;88(8):1842-1851.
93. Boyer JD, Zitelli JA, Brodland DG, D’Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002;47(6):885-892.
94. Ellis DL, Davis RS. Evidence­based management of primary and localized Merkel cell carcinoma: a review. Int J Dermatol. 2013;52(10): 1248-1258.
95. Balakrishnan V, Berry S, Stew B, Sizeland A. Benefits of combined modality treatment of Merkel cell carcinoma of the head and neck: single institution experience. J Laryngol Otol. 2013;127(9):908-916.
96. Poulsen M, Rischin D. Merkel cell carcinoma-current therapeutic options. Expert Opin Pharmacother. 2003;4(12):2187-2192.
97. Tuskada A, Fujimura T, Hashimoto A, et al. Successful local control of cutaneous Merkel cell carcinoma on the eyelid with CyberKnife radiosurgery. Eur J Dermatol. 2013;23(5):725-726.
98. Veness M, Howle J. Radiotherapy alone in patients with Merkel cell carcinoma: the Westmead Hospital experience of 41 patients. Australas J Dermatol. 2015;56(1):19-24.
99. Hruby G, Scolyer RA, Thompson JF. The important role of radiation treatment in the management of Merkel cell carcinoma. Br J Dermatol. 2013;169(5):975-982.
100. Jouary T, Leyral C, Dreno B, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol. 2012;23(4): 1074-1080.
101. Kokoska ER, Kokoska MS, Collins BT, Stapleton DR, Wade TP. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg. 1997;174(6):688-693.
102. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of post­operative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys. 1995;31(2):325-331.
103. Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol. 2006;142(6): 693-700.
104. Jabbour J, Cumming R, Scolyer RA, Hruby G, Thompson JF, Lee S. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early­stage disease-results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol. 2007;14(6): 1943-1952.
105. Medina-Franco J, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1,024 cases. Ann Surg Oncol. 2001;8(3): 204-208.
106. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007;25(9):1043-1047.
107. Veness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg. 2005;75(5): 275-281.
108. Hasan S, Liu L, Triplet J, Li Z, Mansur D. The role of postoperative radiation and chemoradiation in Merkel cell carcinoma: a systematic review of the literature. Front Oncol. 2013;3:276.
109. Fang L, Parvathaneni U, Nghiem P. Surgery with or without radiotherapy for Merkel cell carcinoma. Int J Radiat Oncol. 2008;72(1). Supplement:S508.
110. George TK, Di Sant’agnese PA, Bennett JM. Chemotherapy for metastatic Merkel cell carcinoma. Cancer. 1985;56(5):1034-1038.
111. McAfee WJ, Morris CG, Mendenhall CM, Werning JW, Mendenhall NP, Mendenhall WM. Merkel cell carcinoma: treatment and outcomes. Cancer. 2005;104(8):1761-1764.
112. Redmond J 3rd, Perry J, Sowray P, Vukelja SJ, Dawson N. Chemotherapy of disseminated Merkel­cell carcinoma. Am J Clin Oncol. 1991; 14(4):305-307.
113. Azagury M, Chevallier B, Atlan D, Graic Y, Dayot JP, Thomine E. VP­16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long­term remission. Am J Clin Oncol. 1993;16(2):102-104.
114. Voog E, Biron P, Martin JP, Blay JY. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer. 1999;85(12):2589-2595.
115. Wobser M, Kürzinger N, Ugurel S, Bröcker EB, Becker JC. Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy. J Dtsch Dermatol Ges. 2009;7(6): 521-525.
116. Schlaak M, Podewski T, Von Bartenwerffer W, et al. Induction of durable responses by oral etoposide monochemotherapy in patients with metastatic Merkel cell carcinoma. Eur J Dermatol. 2012;22(2): 187-191.
117. Tai PT, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, Gilchrist J. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol. 2000;18(12): 2493-2499.
118. Pollack SV, Goslen JB. Small­cell neuroepithelial tumor of skin: a Merkel­cell neoplasm? J Dermatol Surg Oncol. 1982;8(2):116-122.
119. Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS. Treatment of Merkel cell carcinoma. Am J Clin Oncol. 2004;27(5):510-515.
120. Eng TY, Naguib M, Fuller CD, Jones WE 3rd, Herman TS. Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol. 2004;27(6):576-583.
121. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300-2309.
122. Desch L, Kunstfeld R. Merkel cell carcinoma: chemotherapy and emerging new therapeutic options. J Skin Cancer. 2013;2013:327150.
123. Garibyan L, Cotter SE, Hansen JL, et al. Palliative treatment for in­transit cutaneous metastases of Merkel cell carcinoma using surface­mold computer­optimized high­dose­rate brachytherapy. Cancer J. 2013; 19(4):283-287.
124. Mouchet N, Coquart N, Lebonvallet N, et al. Comparative transcriptional profiling of human Merkel cells and Merkel cell carcinoma. Exp Dermatol. 2014;23(12):928-930.
125. Gomez B, He L, Tsai YC, Wu TC, Viscidi RP, Hung CF. Creation of a Merkel cell polyomavirus small T antigen­expressing murine tumor model and a DNA vaccine targeting small T antigen. Cell Biosci. 2013;3(1):29.
126. Fernández-Figueras MT, Puig L, Musulén E, et al. Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod Pathol. 2007;20(1):90-101.
127. Kartha RV, Sundram UN. Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase­based tumorigenesis. Mod Pathol. 2008;21(2):96-104.
128. Samlowski WE, Moon J, Tuthill RJ, et al. A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group study (S0331). Am J Clin Oncol. 2010;33(5):495-499.
129. Feinmesser M, Halpern M, Kaganovsky E, et al. c­kit expression in primary and metastatic Merkel cell carcinoma. Am J Dermatopathol. 2004;26(6):458-462.
130. Su LD, Fullen DR, Lowe L, Uherova P, Schnitzer B, Valdez R. CD117 (KIT receptor) expression in Merkel cell carcinoma. Am J Dermatopathol. 2002;24(4):289-293.
131. Strong S, Shalders K, Carr R, Snead DR. KIT receptor (CD117) expression in Merkel cell carcinoma. Br J Dermatol. 2004;150(2):384-385.
132. Krasagakis K, Fragiadaki I, Metaxari M, et al. KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of Merkel cell carcinoma in vitro. J Cell Physiol. 2011;226(4):1099-1109.
133. di Bartolomeo M, Bajetta E, Buzzoni R, et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer. 1996;77(2): 402-408.
134. Meier G, Waldherr C, Herrmann R, Maecke H, Mueller-Brand J, Pless M. Successful targeted radiotherapy with 90Y­DOTATOC in a patient with Merkel cell carcinoma. A case report. Oncology. 2004;66(2): 160-163.
135. Fakiha M, Letertre P, Vuillez JP, Lebeau J. Remission of Merkel cell tumor after somatostatin analog treatment. J Cancer Res Ther. 2010; 6(3):382-384.
136. Richetta AG, Mancini M, Torroni A, et al. Total spontaneous regression of advanced Merkel cell carcinoma after biopsy: review and a new case. Dermatol Surg. 2008;34(6):815-822.
137. Wooff JC, Trites JR, Walsh NM, Bullock MJ. Complete spontaneous regression of metastatic Merkel cell carcinoma: a case report and review of the literature. Am J Dermatopathol. 2010;32(6):614-617.
138. Krishna SM, Kim CN. Merkel cell carcinoma in a patient treated with adalimumab: case report. Cutis. 2011;87(2):81-84.
139. Linn-Rasker SP, van Albada-Kuipers GA, Dubois SV, Janssen K, Zweers PG. Merkel cell carcinoma during treatment with TNF­alpha inhibitors: coincidence or warning? Ned Tijdschr Geneeskd. 2012; 156(22):A4464.
140. Inoue T, Yoneda K, Manabe M, Demitsu T. Spontaneous regression of Merkel cell carcinoma: a comparative study of TUNEL index and tumor­infiltrating lymphocytes between spontaneous regression and non­regression group. J Dermatol Sci. 2000;24(3):203-211.
141. Koba S, Paulson KG, Nagase K, et al. Diagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma. PLoS One. 2012;7(7):e41465.
142. Biver-Dalle C, et al. Use of interferon­alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus. Acta Oncol. 2011;50(3):479-480.
143. Willmes C, Adam C, Alb M, et al. Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens. Cancer Res. 2012;72(8):2120-2128.
144. Balducci M, De Bari B, Manfrida S, D’Agostino GR, Valentini V. Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): a case report. Tumori. 2010;96(3):508-511.
145. Schrama D, Reisfeld RA, Becker JC. Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov. 2006;5(2):147-159.
146. Graves CA, Jones A, Reynolds J, et al. Neuroendocrine Merkel cell carcinoma is associated with mutations in key DNA repair, epigenetic and apoptosis pathways: a case­based study using targeted massively parallel sequencing. Neuroendocrinology. 2015;101(2):112-119.
147. Xie H, Liu T, Wang N, et al. TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma. Oncotarget. 2014;5(20):10048-10057.